EPCAM and colorectal cancer: Accordingly, various studies using α-amanitin-conjugated anti-epithelial cell adhesion molecule (EpCAM) antibody in murine models suggest their interest in colorectal cancer, pancreatic carcinomas, and various EpCAM-expressing malignancies [53,54,55].